Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload
Public ClinicalTrials.gov record NCT00235391. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an open-label, non-randomized, multi-center trial designed to provide expanded access of deferasirox to patients with congenital disorders of red blood cells and chronic iron overload from blood transfusions who cannot adequately be treated with locally approved iron chelators.
Study identification
- NCT ID
- NCT00235391
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 1,683 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 2 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2005 (Type not available)
- Primary completion
- Oct 2008 (Actual)
- Completion
- Oct 2008 (Actual)
- Last update posted
- Jun 7, 2011
2005 – 2008
United States locations
- U.S. sites
- 27
- U.S. states
- 18
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arkansas Children's Hospital, UAMS College of Medicine | Little Rock | Arkansas | 72202 | — |
| Alta Bates Comprehensive Cancer Center | Berkeley | California | 94704 | — |
| Children's Hospital of Orange County | Orange | California | 92868 | — |
| Children's Hospital and Health Center of San Diego | San Diego | California | 92123 | — |
| Stanford University | Stanford | California | 94305 | — |
| Alfred I. Dupong Hospital for Children | Wilmington | Delaware | 19803 | — |
| Osler Medical, Inc. | Melbourne | Florida | 32901 | — |
| Hematalogy Oncology Associates | Pensacola | Florida | 32501 | — |
| Tampa Children's Hospital at St. Joseph's Hospital | Tampa | Florida | 33607 | — |
| James A. Haley Veterans Hospital | Tampa | Florida | 33612 | — |
| Backus Children's Hospital, Memorial Health University Medical Center | Savannah | Georgia | 31403 | — |
| Hematalogy Oncology Clinic | Baton Rouge | Louisiana | 70808 | — |
| Borgess Hospital | Kalamazoo | Michigan | 49048 | — |
| Children's Hospitals and Clinics of Minnesota | Minneapolis | Minnesota | 55405 | — |
| University of Mississippi Medical Center | Jackson | Mississippi | 39762 | — |
| Children's Mercy Hospital | Kansas City | Missouri | 64108 | — |
| The Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | — |
| Schneider Children's Hospital | New Hyde Park | New York | 11040 | — |
| PCTI | Columbus | Ohio | 43205 | — |
| The Children's Medical Center of Dayton | Dayton | Ohio | 45404 | — |
| Oregon Health & Science University | Portland | Oregon | 97239 | — |
| Hershey Medical Center | Hershey | Pennsylvania | 17033-0850 | — |
| Children's Hospitals of Pittsburgh | Pittsburgh | Pennsylvania | 15213 | — |
| Texas Children's Hospital | Houston | Texas | 77030 | — |
| Children's Hospital of the Kings Daughters | Norfolk | Virginia | 23507 | — |
| VCU Pediatric Hematology/Oncology | Richmond | Virginia | 23219 | — |
| University of Washington Seattle Cancer Care Alliance | Seattle | Washington | 98195 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 114 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00235391, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 7, 2011 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00235391 live on ClinicalTrials.gov.